- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.01. | Johnson & Johnson Latest to Reach Drug Price Deal with Trump White House | ||
| 12.01. | Aragen Launches CHOMax Platform to Accelerate Path from DNA to Clinical Supply | ||
| 09.01. | Pierre Fabre, Iktos Enter AI-Driven Drug Discovery Alliance | ||
| 09.01. | Codexis and Axolabs Partner to Advance Enzymatic RNA Manufacturing | ||
| 09.01. | Schreiner MediPharm Expands Needle-Trap Portfolio | ||
| 09.01. | Psilera Appoints Magali Haas Chief Medical Officer | ||
| 09.01. | Halozyme Partners with Takeda to Develop and Commercialize Vedolizumab | ||
| 09.01. | Veeva, BioMarin Enter Long-Term Strategic Partnership | ||
| 09.01. | AstraZeneca Taps Rick Suarez as US President & Head of the US Biopharmaceuticals Business Unit | ||
| 07.01. | Daiichi and GENESIS Will Commercialize VANFLYTA in Parts of Europe | ||
| 07.01. | Viking Therapeutics Hires Neil Aubuchon as Chief Commercial Officer | ||
| 07.01. | Eramol Nears Completion of New Sterile Manufacturing Facility at Sevenoaks | ||
| 07.01. | Qureight Promotes Dr. Steven Bishop to Chief Medical Officer | ||
| 07.01. | Ascidian Therapeutics, Forge Biologics Partner to Advance Stargardt Treatment | ||
| 07.01. | Sharp Sterile Manufacturing to Invest $28M in Lee, Massachusetts Site | ||
| 07.01. | Novo Nordisk's International Operations Adopt Veeva Vault CRM | ||
| 07.01. | CareDx, 10x Genomics Establish Multiomics Research Initiative | ||
| 06.01. | GBI Biomanufacturing Appoints New President Jesse McCool | ||
| 06.01. | BostonGene, AstraZeneca Partner to Advance Oncology Drug Development | ||
| 06.01. | Premier Research Names Siân Ratcliffe Smethurst Chief Operating Officer | ||
| 06.01. | ProBioGen, Zag Bio Partner to Accelerate Thymus-Targeted Bifunctional Antibody Program | ||
| 06.01. | Artis BioSolutions to Acquire Syngoi Technologies | ||
| 06.01. | GeneDx Taps Dr. Linda Genen as Chief Medical Officer | ||
| 06.01. | Title21 Health Solutions Acquires MyCellHub and Its MES Platform | ||
| 06.01. | Autolus Therapeutics Explores the Feasibility of Adopting Cellares' Cell Shuttle Platform |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.